Recombinant Human FPR2 Protein，His

FPR2, or Formyl Peptide Receptor 2, is a member of the G protein-coupled receptor (GPCR) family and plays a crucial role in the immune response and inflammation. It is primarily expressed in immune cells such as neutrophils and macrophages, where it mediates the chemotactic response to formylated peptides, guiding these cells to sites of infection or injury. Research into FPR2 has gained momentum due to its potential implications in various pathological conditions, including autoimmune diseases, cancer, and neurodegenerative disorders. The receptor's ability to recognize both host-derived and microbial cues makes it a key player in distinguishing between self and non-self, which is essential for maintaining homeostasis in the immune system. Furthermore, studies have shown that FPR2 can influence the activation of leukocytes and modulate the release of pro-inflammatory cytokines, linking it to the regulation of inflammation. The development of recombinant FPR2 proteins allows for advanced studies into its structure-function relationships and interactions with ligands, as well as potential therapeutic applications. Through the study of FPR2 and its recombinant forms, researchers hope to elucidate novel mechanisms of immune modulation and identify new drug targets to combat diseases associated with dysregulated immune responses. Understanding the biology of FPR2 may provide insights into its role in health and disease, paving the way for innovative strategies in immunotherapy and personalized medicine.